Strata skin sciences, inc. (SSKN)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Revenues, net

31,586

29,855

31,763

-

-

-

-

-

-

-

-

Revenues

-

-

-

30,707

18,495

915

536

278

-

-

-

Cost of revenues

11,316

12,735

12,998

12,636

13,719

4,935

4,341

2,042

-

-

-

Gross profit

20,270

17,120

18,765

18,071

4,776

-4,020

-3,805

-1,764

-

-

-

Operating expenses:
Engineering and product development

1,002

1,065

1,711

1,929

2,029

1,641

3,782

6,792

9,656

11,496

10,950

Selling and marketing

12,003

10,624

11,249

12,102

9,194

-

-

-

-

-

-

Selling and marketing

-

-

-

-

-

3,140

15,536

-

-

-

-

General and administrative

10,275

8,786

7,604

7,637

10,028

7,821

-

14,169

10,806

8,738

7,631

Impairment of long-lived assets

-

-

-

-

-

-

1,011

-

-

-

-

Total operating expenses

23,280

20,475

20,564

21,668

21,251

12,602

20,329

20,961

-

-

-

Loss from operations

-3,010

-3,355

-1,799

-3,597

-16,475

-16,622

-24,134

-22,725

-20,462

-20,234

-18,581

Other income (expense), net:
Interest income

-

-

-

-

-

-

8

32

54

31

45

Interest expense, net

515

1,142

3,196

4,900

10,200

2,372

564

-

-

-

-

Loss on extinguishment of debt

-414

0

-20,160

0

-

-

-

-

-

-

-

Change in fair value of warrant liability

-

-

-595

-5,396

-1,814

-

-

-

-

-

-

Change in fair value of embedded conversion feature

-

-

3,158

-

-

-

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

8,103

-296

-

-

-

-

Write-off of unamortized loan costs

-

-

-

-

-

-

983

-

-

-

-

Gain on sale of assets

-

-

-

-

-

16

0

-

-

-

-

Registration rights liquidated damages

-

-

-

-

-

3,420

0

-

-

-

-

Other income, net

0

200

17

21

33

150

21

20

23

280

83

Other (expense) income, net

-929

-942

-19,586

517

-8,353

2,477

-1,814

52

77

312

128

Loss before income taxes

-3,939

-4,297

-21,385

-3,080

-24,828

-14,145

-

-

-

-

-

Income tax (expense) benefit

-149

-264

129

255

119

0

-

-

-

-

-

Net loss

-3,790

-4,033

-21,514

-3,335

-24,947

-14,145

-25,948

-22,673

-20,384

-19,922

-18,452

Deemed dividend related to warrant modification

-

-

-

-

2,962

1,887

0

-

-

-

-

Loss attributable to common shares

-3,597

-2,909

-8,851

-

-27,909

-16,032

-25,948

-

-

-

-

Amount, after deduction of tax and noncontrolling interests of income (loss) available to preferred stockholders.

-193

-1,124

-12,663

-

-

-

-

-

-

-

-

Loss per common share:
Basic (in dollars per share)

-0.11

-0.15

-3.26

-1.57

-3.27

-

-

-

-

-

-

Diluted (in dollars per share)

-0.11

-0.15

-3.26

-3.77

-3.27

-

-

-

-

-

-

Shares used in computing loss per common share:
Basic (in shares)

31,978

19,589

2,713

2,119

8,536

-

-

-

-

-

-

Diluted (in shares)

31,978

19,589

2,713

2,315

8,536

-

-

-

-

-

-

Net loss per share - basic and diluted (in dollars per share)

-

-

-

-

-

-3.03

-6.05

-0.74

-0.80

-0.83

-0.96

Shares used in computing net loss per basic and diluted (in shares)

-

-

-

-

-

5,295

4,289

30,762

-

-

-

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of preferred stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit

-42.24

-55.20

-1,212.47

0.00

-

-

-

-

-

-

-

Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS) of preferred stock.

4

20

10

0

-

-

-

-

-

-

-

Foreign currency translation adjustments

-

-

-2

1

1

-

-

-

-

-

-

Foreign currency translation adjustments

-

-

-

-

-

0

-

-

-

-

-

Comprehensive loss

-

-

-21,516

-3,334

-27,908

-16,032

-

-

-

-

-

Basic and diluted weighted average number of common shares outstanding

-

-

-

-

-

-

-

-

25,415

24,043

19,293